FDA Issues Warning Against Off-Brand Versions of Popular Diabetes, Weight Loss Drugs
The FDA is cautioning people against using generic versions of Ozempic and Wegovy. The FDA is cautioning people against using generic versions of Ozempic and Wegovy, which are commonly used for weight loss, as they may not have the same ingredients as the original medications and could be dangerous or ineffective.
New York United States Wikimedia Commons Captjayruffins Drug Administration Office Novo Nordisk Office Of Regulatory Affairs
Source: hngn.com